WASHINGTON — The Trump administration’s new plan to pay for certain drugs in Medicare based on international prices quickly set off a war with the drug industry after it was unveiled Thursday — and both sides are charging ahead with aggressive statements that the other is ignoring patients.

The trade group for drug makers, PhRMA, called the proposal “price controls” and said it was “disappointed the administration put the needs of patients aside with these proposals.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • To Bang Ding Ow

    I don’t think anyone wants any prices. Fair prices are needed. EU has price controls and US does not. Plain and simple.

    • G.M.: wrong.

      They’re paying less. We’re paying MORE.

      They need to pay more. We need to pay LESS. That is “fair,” lady.

      Get a clue, please. Thanks.

  • Simple fact of the matter is that the pharmaceutical industry all inclusive has lived high on the hog. They have legislators in their back pocket and know it that by scaring the populous they will win. Stern and bold action is needed. It will be interesting how far each side gives.

    My conjecture is only executive action will resolve the issues at hand. Pharma is going to scream that they are the sacrificial lamb. May be it is time as the lamb has become little too rounded and needs to go on a diet. This is a better choice for everyone rather than other alternates.

    • To the point: what DJT wants, is the pharms make Europe/Canada to PAY THEIR FAIR SHARE.

      Europe/Canada, you have been leeching off the USA for decades, the bill is NOW DUE .. deal with it like adults.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy